Patents Assigned to MURAMI PHARMA, INC
  • Patent number: 9757328
    Abstract: The present invention relates to formulations of gelled lysozyme achieved by the addition of water to a lysozyme suspension in a solvent, such as an alcohol, with retention of enzymatic activity. It was surprisingly discovered that lysozyme itself is a gelling substance (self-gel) and, therefore, it can be advantageously formulated into topical compositions without the addition of other gelling substances such as cellulose, starch or other polysaccharides. The activity of the lysozyme is enhanced as compared to other formulations of comprising lysozyme. The formulations contained in the present invention are useful in methods in the fields of therapeutics, disinfectants, sanitizers, personal hygiene, and cosmetics for human and veterinary use.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 12, 2017
    Assignee: Murami Pharma, Inc.
    Inventors: Stefano Ferrari, Roelof Rongen
  • Patent number: 9149514
    Abstract: A composition of lysozyme and a pharmaceutically acceptable carrier is active against the papilloma virus in both humans and animals. The composition can be used to treat women suffering from cervical cancer. The composition can also be used to treat cows and horses suffering sarcoids.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: October 6, 2015
    Assignee: MURAMI PHARMA, INC
    Inventor: Stefano Ferrari